Explore
Validate
LearnHPA029974
antibody from Atlas Antibodies
Targeting: FOXM1
FKHL16, HFH-11, HNF-3, INS-1, MPHOSPH2, MPP2, TGT3, trident
Immunohistochemistry
Chromatin ImmunoprecipitationAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Chromatin Immunoprecipitation [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA029974 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA029974, RRID:AB_10670030
- Product name
- Anti-FOXM1
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human FOXM1, Gene description: forkhead box M1, Alternative Gene Names: FKHL16, HFH-11, HNF-3, INS-1, MPHOSPH2, MPP2, TGT3, trident, Validated applications: ChIP, IHC, Uniprot ID: Q08050, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.5 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Validation of Novel Prognostic Biomarkers for Early-Stage Clear-Cell, Endometrioid and Mucinous Ovarian Carcinomas Using Immunohistochemistry
A Phase 0 Trial of Ribociclib in Recurrent Glioblastoma Patients Incorporating a Tumor Pharmacodynamic- and Pharmacokinetic-Guided Expansion Cohort
Chromatin associated SETD3 negatively regulates VEGF expression
Engqvist H, Parris T, Kovács A, Rönnerman E, Sundfeldt K, Karlsson P, Helou K
Frontiers in Oncology 2020;10
Frontiers in Oncology 2020;10
A Phase 0 Trial of Ribociclib in Recurrent Glioblastoma Patients Incorporating a Tumor Pharmacodynamic- and Pharmacokinetic-Guided Expansion Cohort
Tien A, Li J, Bao X, Derogatis A, Kim S, Mehta S, Sanai N
Clinical Cancer Research 2019;25(19):5777-5786
Clinical Cancer Research 2019;25(19):5777-5786
Chromatin associated SETD3 negatively regulates VEGF expression
Cohn O, Feldman M, Weil L, Kublanovsky M, Levy D
Scientific Reports 2016;6(1)
Scientific Reports 2016;6(1)
No comments: Submit comment
Supportive validation
- Submitted by
- Atlas Antibodies (provider)
- Main image
- Experimental details
- ChIP-Exo-Seq composite graph for Anti-FOXM1 (HPA029974, Lot C115795) tested in K562 cells. Strand-specific reads (blue: forward, red: reverse) and IgG controls (black: forward, grey: reverse) are plotted against the distance from a composite set of reference binding sites. The antibody exhibits robust target enrichment compared to a non-specific IgG control and precisely reveals its structural organization around the binding site. Data generated by Prof. B. F. Pugh´s Lab at Cornell University.
